Insider · CIK 0001766666
Kimberly Jo Tzoumakas
Files at STLN (Oncology Institute, Inc.). First filing -, latest -.
In brief
Kimberly Jo Tzoumakas files SEC Form 4 as director at STLN (Oncology Institute, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kimberly Jo Tzoumakas has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | STLN Oncology Institute, Inc. | AGrant or award Common Stock | +29,116 | $0.00 | $0 | 46,301 | Jul 29, 2026 |
| Jul 7, 2026 | STLN Oncology Institute, Inc. | AGrant or award Common Stock | +17,185 | $0.00 | $0 | 17,185 | Jul 9, 2026 |
Questions about Kimberly Jo Tzoumakas
Answered from the filings on this page, as of the latest one.
Is Kimberly Jo Tzoumakas buying or selling?
Kimberly Jo Tzoumakas has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kimberly Jo Tzoumakas's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kimberly Jo Tzoumakas has 0.
Where does Kimberly Jo Tzoumakas file Form 4?
Kimberly Jo Tzoumakas has filed Form 4 at STLN (Oncology Institute, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.